Revlimid sales drive higher-than-expected Bristol Myers results ...Middle East

Devdiscourse - Opinion
Revlimid sales drive higher-than-expected Bristol Myers results
Bristol Myers Squibb Co on Wednesday reported higher-than-expected second-quarter profit as a dropoff in sales of its blockbuster cancer drug Revlimid, which now faces generic competition, was not as steep as projected.

Hence then, the article about revlimid sales drive higher than expected bristol myers results was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Revlimid sales drive higher-than-expected Bristol Myers results )

Apple Storegoogle play

Last updated :

Also on site :